Breaking News Instant updates and real-time market news.

ABT

Abbott

$85.38

0.12 (0.14%)

09:03
07/11/19
07/11
09:03
07/11/19
09:03

Abbott's Alinity s blood screening system approved by FDA

Abbott received FDA approval for its new blood and plasma screening Alinity s System. Alinity s is designed to screen blood and plasma more efficiently within a smaller space versus commercially available competitive systems.

  • 17

    Jul

ABT Abbott
$85.38

0.12 (0.14%)

04/03/19
JPMS
04/03/19
NO CHANGE
Target $175
JPMS
Overweight
JPMorgan remains 'very bullish' on DexCom despite Libre 2.0 uncertainty
The latest DexCom (DXCM) controversy is "whirling speculation" around Abbott's (ABT) Libre 2.0 launch, JPMorgan analyst Robbie Marcus tells investors in a research note. The analyst keeps an Overweight rating on DexCom shares with a $175 price target but expects uncertainty over Libre 2.0 to remain an overhang until it receives U.S. approval. However, he remains "very bullish" on the shares and sees "significant upside" to 2019 estimates. DexComis the best positioned in diabetes longer-term, Marcus contends.
04/15/19
RBCM
04/15/19
NO CHANGE
Target $82
RBCM
Sector Perform
Abbott price target raised to $82 from $77 at RBC Capital
RBC Capital analyst Brandon Henry raised his price target on Abbott to $82 ahead of its Q1 results, saying the "pattern of revenue growth" seen last year should continue this quarter as Core Laboratory, Electrophysiology, Structural Heart, and Diabetes Care product categories "lead the way." The analyst also expects Abbott's organic revenue growth in the Medical Devices segment to come at the high end of guidance, adding that while his new price target implies a multiple of 22.5-times vs. peer group's 21-times, he believes that the company's growth profile justifies the valuation premium. Henry recommends that investors buy the stock on "any weakness".
04/18/19
LSCM
04/18/19
NO CHANGE
Target $100
LSCM
Buy
Investors should buy into Tandem Diabetes 'fire sale,' says Lake Street
Lake Street analyst Brooks O'Neil attributes the recent selloff in shares of Tandem Diabetes (TNDM) to investor fears related to the potential implications of "Medicare For All." Yesterday, the decline also appeared to "draw fuel from the strong growth" Abbott (ABT) reported for its Libre glucose monitor for diabetics, O'Neil tells investors in a research note titled "Fire Sale. Should You Buy? Yes. There Is No Fire. Affirm BUY, $100 PT." The analyst doubts the healthcare system will be changed significantly and on Libre, he says, "We're sorry, but we believe investors are either badly confused or just plain wrong." Abbott offers a low-cost version of the monitoring system but does not compete in any way with Tandem in its pump market, says the analyst. Rather, O'Neil thinks there are "potentially significant positives" for Tandem Diabetes related to the "enormous success" of Abbott's Libre franchise. The analyst sees an "extraordinarily positive" outlook for Tandem Diabetes and recommends buying the shares on the recent pullback. He affirms a Buy rating on the shares with a $100 price target.
04/29/19
PIPR
04/29/19
NO CHANGE
Target $165
PIPR
Overweight
Piper reiterates Overweight on DexCom after 'robust' teen survey results
There were 8,042 responses to Piper Jaffray's teen survey in February and March, of which 1,707 have diabetes or a member of their household does, analyst JP McKim tells investors in a research note. The survey implies underlying continuous glucose monitoring market growth of close to 58%, says the analyst. Abbott (ABT) reported 70% Libre growth in Q1 and DexCom (DXCM) reports May 1, McKim points out. He expects "continued strong growth" from DexCom following the "robust" survey results and reiterates an Overweight rating on the shares with a $165 price target.

TODAY'S FREE FLY STORIES

MGM

MGM Resorts

$28.85

-0.555 (-1.89%)

05:08
07/18/19
07/18
05:08
07/18/19
05:08
Downgrade
MGM Resorts rating change  »

MGM Resorts downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

EXP

Eagle Materials

$86.46

-0.245 (-0.28%)

05:06
07/18/19
07/18
05:06
07/18/19
05:06
Downgrade
Eagle Materials rating change  »

Eagle Materials…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

  • 06

    Aug

  • 21

    Aug

  • 04

    Sep

  • 13

    Nov

ATI

Allegheny Technologies

$24.47

-0.415 (-1.67%)

05:05
07/18/19
07/18
05:05
07/18/19
05:05
Downgrade
Allegheny Technologies rating change  »

Allegheny Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 06

    Aug

ARNC

Arconic

$25.29

-0.49 (-1.90%)

05:05
07/18/19
07/18
05:05
07/18/19
05:05
Downgrade
Arconic rating change  »

Arconic downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USCR

U.S. Concrete

$50.87

-0.96 (-1.85%)

05:04
07/18/19
07/18
05:04
07/18/19
05:04
Downgrade
U.S. Concrete rating change  »

U.S. Concrete downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 13

    Nov

AMD

AMD

$33.59

-0.23 (-0.68%)

, INTC

Intel

$49.39

0.22 (0.45%)

04:59
07/18/19
07/18
04:59
07/18/19
04:59
Downgrade
AMD downgraded to Neutral from Buy at Mizuho »

Mizuho analyst Vijay…

AMD

AMD

$33.59

-0.23 (-0.68%)

INTC

Intel

$49.39

0.22 (0.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 30

    Jul

04:55
07/18/19
07/18
04:55
07/18/19
04:55
General news
Jobless Claims to be reported at 08:30 »

Week of 7/13 Jobless…

04:55
07/18/19
07/18
04:55
07/18/19
04:55
General news
Breaking General news story  »

6-Month Bill Announcement…

GMRE

Global Medical REIT

$10.51

-0.15 (-1.41%)

04:55
07/18/19
07/18
04:55
07/18/19
04:55
Conference/Events
Global Medical REIT management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 08

    Aug

TORC

ResTORbio

$10.42

0.19 (1.86%)

04:55
07/18/19
07/18
04:55
07/18/19
04:55
Conference/Events
ResTORbio management to meet with Wedbush »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

SUPV

Grupo Supervielle

$8.12

0.13 (1.63%)

04:55
07/18/19
07/18
04:55
07/18/19
04:55
Conference/Events
Grupo Supervielle management to meet with UBS »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 19

    Jul

04:55
07/18/19
07/18
04:55
07/18/19
04:55
General news
Philadelphia Fed Business Outlook Survey General Conditions Index to be reported at 08:30 »

July Philadelphia Fed…

04:55
07/18/19
07/18
04:55
07/18/19
04:55
General news
Leading Indicators to be reported at 10:00 »

June Leading Indicators…

CAMP

CalAmp

$10.82

-0.46 (-4.08%)

04:55
07/18/19
07/18
04:55
07/18/19
04:55
Conference/Events
CalAmp participates in a conference call with Northland »

Conference call with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 24

    Jul

  • 06

    Aug

04:55
07/18/19
07/18
04:55
07/18/19
04:55
General news
Breaking General news story  »

Week of 7/12 EIA Natural…

04:55
07/18/19
07/18
04:55
07/18/19
04:55
General news
Breaking General news story  »

4-Week Bill Auction to be…

CASY

Casey's General Stores

$160.43

0.08 (0.05%)

04:55
07/18/19
07/18
04:55
07/18/19
04:55
Conference/Events
Casey's General Stores management to meet with Northcoast »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 13

    Nov

OPNT

Opiant Pharmaceuticals

$13.24

-0.25 (-1.85%)

04:55
07/18/19
07/18
04:55
07/18/19
04:55
Conference/Events
Opiant Pharmaceuticals management to meet with Northland »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 19

    Jul

ACAD

Acadia

$25.56

-0.72 (-2.74%)

, BIIB

Biogen

$229.39

-2.17 (-0.94%)

04:55
07/18/19
07/18
04:55
07/18/19
04:55
Conference/Events
Alzheimer's Association to hold a conference »

Alzheimer's…

ACAD

Acadia

$25.56

-0.72 (-2.74%)

BIIB

Biogen

$229.39

-2.17 (-0.94%)

CRL

Charles River

$135.30

0.08 (0.06%)

DGX

Quest Diagnostics

$100.18

-1.28 (-1.26%)

ESALY

Eisai

$0.00

(0.00%)

PKI

PerkinElmer

$95.10

-0.24 (-0.25%)

RHHBY

Roche

$0.00

(0.00%)

MRK

Merck

$81.93

0.36 (0.44%)

NSTG

NanoString

$30.44

-0.06 (-0.20%)

PRAH

PRA Health

$98.05

-0.43 (-0.44%)

QTRX

Quanterix

$31.45

0.37 (1.19%)

SYNH

Syneos Health

$47.64

-1.07 (-2.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 23

    Jul

  • 25

    Jul

  • 25

    Jul

  • 29

    Jul

  • 30

    Jul

  • 31

    Jul

  • 31

    Jul

  • 31

    Jul

  • 01

    Aug

  • 06

    Aug

  • 06

    Aug

  • 08

    Aug

  • 18

    Aug

  • 19

    Aug

  • 26

    Aug

  • 02

    Sep

  • 09

    Sep

  • 13

    Sep

  • 16

    Sep

  • 20

    Sep

  • 02

    Oct

  • 04

    Nov

CGC

Canopy Growth

$36.57

1.015 (2.85%)

04:55
07/18/19
07/18
04:55
07/18/19
04:55
Conference/Events
Canopy Growth management to meet with Seaport Global »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

04:55
07/18/19
07/18
04:55
07/18/19
04:55
Conference/Events
The Brookings Institution to hold a conference on the US-China Trade War »

The Global Economy &…

04:55
07/18/19
07/18
04:55
07/18/19
04:55
Conference/Events
House Judiciary Committee to hold a hearing »

The Subcommittee on…

04:55
07/18/19
07/18
04:55
07/18/19
04:55
General news
Breaking General news story  »

8-Week Bill Auction to be…

04:55
07/18/19
07/18
04:55
07/18/19
04:55
General news
Breaking General news story  »

Week of 7/17 Fed Balance…

04:55
07/18/19
07/18
04:55
07/18/19
04:55
General news
Breaking General news story  »

New York Federal Reserve…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.